Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Elmarakby, Ahmed A ^a   Faulkner, Jessica ^a   Baban, Babak ^a   Sullivan, Jennifer C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; COLLAGEN; CREATININE; HEME OXYGENASE 1; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTOPORPHYRIN COBALT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STANNSOPORFIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT RESPONSE; URINARY EXCRETION;

EID: 84868295035     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/957235     Document Type: Article

References (52)

1. Forlenza G. P., Rewers M., marian.rewers@ucdenver.edu The epidemic of type 1 diabetes: what is it telling us? Current Opinion in Endocrinology, Diabetes and Obesity 2011 18 4 248 251 10.1097/MED.0b013e32834872ce
2. Wang Y. C., ycw2102@columbia.edu McPherson K., Marsh T., Gortmaker S. L., Brown M., Health and economic burden of the projected obesity trends in the USA and the UK. The Lancet 2011 378 9793 815 825 10.1016/S0140-6736(11)60814-3
3. Barnett A., Prevention of loss of renal function over time in patients with diabetic nephropathy. American Journal of Medicine 2006 119 5 S40 S47 2-s2.0-33645069186 10.1016/j.amjmed.2006.01.013
4. Luft C., Haller H., Hypertension-induced renal injury: is mechanically mediated interstitial inflammation involved? Nephrology Dialysis Transplantation 1995 10 1 9 11 2-s2.0-0028843073
5. Ritz E., Schmieder R. E., Pollock C. A., Renal protection in diabetes: lessons from ONTARGET® Cardiovascular Diabetology 2010 9, article 60 2-s2.0-77957203809 10.1186/1475-2840-9-60
6. Dominguez L. J., Galioto A., Pineo A., Ferlisi A., Ciaccio M., Putignano E., Belvedere M., Costanza G., Barbagallo M., Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus. Journal of the American College of Nutrition 2010 29 1 1 6 2-s2.0-77956489908
7. Paravicini T. M., Touyz R. M., NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008 31 S170 S180 2-s2.0-41149150716
8. Arora S., Vaishya R., Dabla P. K., Singh B., NAD(P)H oxidases in coronary artery disease. Advances in Clinical Chemistry 2010 50 65 86 2-s2.0-77954040890 10.1016/S0065-2423(10)50004-0
9. Moon J.-Y., Tanimoto M., Gohda T., Hagiwara S., Yamazaki T., Ohara I., Murakoshi M., Aoki T., Ishikawa Y., Lee S.-H., Jeong K.-H., Lee T.-W., Ihm C.-G., Lim S. J., Tomino Y., yasu@med.jutendo.ac.jp Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-Ay/Ta mice. American Journal of Physiology 2011 300 6 F1271 F1282 10.1152/ajprenal.00065.2010
10. Satoh M., Fujimoto S., Haruna Y., Arakawa S., Horike H., Komai N., Sasaki T., Tsujioka K., Makino H., Kashihara N., NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. American Journal of Physiology 2005 288 6 F1144 F1152 2-s2.0-21044436751 10.1152/ajprenal.00221.2004 (Pubitemid 40677084)
11. Tojo A., Asaba K., Onozato M. L., Suppressing renal NADPH oxidase to treat diabetic nephropathy. Expert Opinion on Therapeutic Targets 2007 11 8 1011 1018 2-s2.0-34547788748 10.1517/14728222.11.8.1011 (Pubitemid 47232619)
12. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J. L., Abboud H. E., Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. Journal of Biological Chemistry 2005 280 47 39616 39626 2-s2.0-28044455523 10.1074/jbc.M502412200 (Pubitemid 41713921)
13. Kashihara N., Haruna Y., Kondeti V. K., Kanwar Y. S., Oxidative stress in diabetic nephropathy. Current Medicinal Chemistry 2010 17 34 4256 4269 2-s2.0-78650657305 10.2174/092986710793348581
14. Chow F. Y., Nikolic-Paterson D. J., Atkins R. C., Tesch G. H., Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrology Dialysis Transplantation 2004 19 12 2987 2996 2-s2.0-11244267207 10.1093/ndt/gfh441 (Pubitemid 40057619)
15. Chow F. Y., Nikolic-Paterson D. J., Ma F. Y., Ozols E., Rollins B. J., Tesch G. H., Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia 2007 50 2 471 480 2-s2.0-34447344360 10.1007/s00125-006-0497-8
16. Chow F. Y., Nikolic-Paterson D. J., Ozols E., Atkins R. C., Rollin B. J., Tesch G. H., Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney International 2006 69 1 73 80 2-s2.0-30944456936 10.1038/sj.ki.5000014 (Pubitemid 43117741)
17. Chow F. Y., Nikolic-Paterson D. J., Ozols E., Atkins R. C., Tesch G. H., Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. Journal of the American Society of Nephrology 2005 16 6 1711 1722 2-s2.0-26944480830 10.1681/ASN.2004070612 (Pubitemid 41716477)
18. Nguyen D., Ping F., Mu W., Hill P., Atkins R. C., Chadban S. J., Macrophage accumulation in human progressive diabetic nephropathy. Nephrology 2006 11 3 226 231 2-s2.0-33744792937 10.1111/j.1440-1797.2006.00576.x (Pubitemid 43829442)
19. Rivero A., Mora C., Muros M., García J., Herrera H., Navarro-González J. F., Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clinical Science 2009 116 6 479 492 2-s2.0-65249102179 10.1042/CS20080394
20. Tesch G. H., Greg.Tesch@monash.edu.au Lim A. K.H., Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. American Journal of Physiology 2011 300 2 F301 F310 10.1152/ajprenal.00607.2010
21. Abraham N. G., Cao J., Sacerdoti D., Li X., Drummond G., Heme oxygenase: the key to renal function regulation. American Journal of Physiology 2009 297 5 F1137 F1152 2-s2.0-70350719355 10.1152/ajprenal.90449.2008
22. Nath K. A., Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney International 2006 70 3 432 443 2-s2.0-33746552172 10.1038/sj.ki.5001565 (Pubitemid 44141569)
23. Burgess A., Li M., Vanella L., Kim D. H., Rezzani R., Rodella L., Sodhi K., Canestraro M., Martasek P., Peterson S. J., Kappas A., Abraham N. G., Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension 2010 56 6 1124 1130 2-s2.0-78650420124 10.1161/HYPERTENSIONAHA.110.151423
24. Cao J., Drummond G., Inoue K., Sodhi K., Li X. Y., Omura S., Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress. International Journal of Molecular Sciences 2008 9 12 2388 2406 2-s2.0-58149250329 10.3390/ijms9122388
25. Elmarakby A. A., Faulkner J., Posey S. P., Sullivan J. C., Induction of hemeoxygenase-1 attenuates the hypertension and renal inflammation in spontaneously hypertensive rats. Pharmacological Research 2010 62 5 400 407 2-s2.0-77956941393 10.1016/j.phrs.2010.07.005
26. Jadhav A., Torlakovic E., Ndisang J. F., Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. American Journal of Physiology 2009 296 3 F521 F534 2-s2.0-66049154851 10.1152/ajprenal.00510. 2007
27. Saleh M. A., Boesen E. I., Pollock J. S., Savin V. J., Pollock D. M., Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes. Diabetologia 2011 54 979 988 2-s2.0-78650581984 10.1007/s00125-010-2021-4
28. Sasser J. M., Sullivan J. C., Hobbs J. L., Yamamoto T., Pollock D. M., Carmines P. K., Pollock J. S., Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. Journal of the American Society of Nephrology 2007 18 1 143 154 2-s2.0-33845979878 10.1681/ASN.2006030208 (Pubitemid 46053429)
29. Mozaffari M. S., Mmozaffa@mail.mcg.edu Baban B., Liu J. Y., Abebe W., Sullivan J. C., El-Marakby A., Mitochondrial complex I and NAD(P)H oxidase are major sources of exacerbated oxidative stress in pressure-overloaded ischemic-reperfused hearts. Basic Research in Cardiology 2011 106 2 287 297 10.1007/s00395-011-0150-7
30. Sullivan J. C., Bhatia K., Yamamoto T., Elmarakby A. A., Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats. Hypertension 2010 56 4 658 666 2-s2.0-77957232252 10.1161/HYPERTENSIONAHA.110.153668
31. Elmarakby A. A., aelmarakby@georgiahealth.edu Faulkner J., Al-Shabrawey M., Wang M.-H., Maddipati K. R., Imig J. D., Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. American Journal of Physiology 2011 301 5 R1307 R1317 10.1152/ajpregu.00759.2010
32. Nakajima K., Tohyama Y., Kohsaka S., Kurihara T., Protein kinase C α requirement in the activation of p38 mitogen-activated protein kinase, which is linked to the induction of tumor necrosis factor α in lipopolysaccharide-stimulated microglia. Neurochemistry International 2004 44 4 205 214 2-s2.0-0242299717 10.1016/S0197-0186(03)00163-3 (Pubitemid 37340131)
33. Yeh C. H., Sturgis L., Haidacher J., Zhang X. N., Sherwood S. J., Bjercke R. J., Juhasz O., Crow M. T., Tilton R. G., Denner L., Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor- κ B transcriptional activation and cytokine secretion. Diabetes 2001 50 6 1495 1504 2-s2.0-0034987093 (Pubitemid 32500185)
34. Elmarakby A. A., aelmarakby@georgiahealth.edu Ibrahim A. S., Faulkner J., Mozaffari M. S., Liou G. I., Abdelsayed R., Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vascular Pharmacology 2011 55 5-6 149 156 10.1016/j.vph.2011.07. 007
35. Ndisang J. F., Lane N., Syed N., Jadhav A., Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 2010 151 2 549 560 2-s2.0-74949102157 10.1210/en.2009-0471
36. Pradhan A., Umezu M., Fukagawa M., Heme-oxygenase upregulation ameliorates angiotensin II-induced tubulointerstitial injury and salt-sensitive hypertension. American Journal of Nephrology 2007 26 6 552 561 2-s2.0-33846431612 10.1159/000098001
37. Aizawa T., Ishizaka N., Taguchi J. I., Nagai R., Mori I., Tang S. S., Ingelfinger J. R., Ohno M., Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 2000 35 3 800 806 2-s2.0-0034065989 (Pubitemid 30165329)
38. Goodman A. I., Chander P. N., Rezzani R., Schwartzman M. L., Regan R. F., Rodella L., Turkseven S., Lianos E. A., Dennery P. A., Abraham N. G., Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. Journal of the American Society of Nephrology 2006 17 4 1073 1081 2-s2.0-33645466388 10.1681/ASN.2004121082
39. Saleh M. A., Pollock J. S., Pollock D. M., dpollock@georgiahealth.edu Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease. Journal of Pharmacology and Experimental Therapeutics 2011 338 1 263 270 10.1124/jpet.111.178988
40. Krag S., Nyengaard J. R., Wogensen L., Combined effects of moderately elevated blood glucose and locally produced TGF- β 1 on glomerular morphology and renal collagen production. Nephrology Dialysis Transplantation 2007 22 9 2485 2496 2-s2.0-34548437070 10.1093/ndt/gfm229 (Pubitemid 47365511)
41. Chen S., Iglesias-de la Cruz M. C., Jim B., Hong S. W., Isono M., Ziyadeh F. N., Reversibility of established diabetic glomerulopathy by anti-TGF- β antibodies in db/db mice. Biochemical and Biophysical Research Communications 2003 300 1 16 22 2-s2.0-0037229517 10.1016/S0006-291X(02)02708-0 (Pubitemid 36042924)
42. Koya D., Hayashi K., Kitada M., Kashiwagi A., Kikkawa R., Haneda M., Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. Journal of the American Society of Nephrology 2003 14 3 S250 S253 2-s2.0-0042867404 (Pubitemid 36903935)
43. Lee S. C., Han S. H., Li J. J., Lee S. H., Jung D. S., Kwak S. J., Kim S. H., Kim D. K., Yoo T. H., Kim J. H., Chang S. H., Han D. S., Kang S. W., Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney International 2009 76 8 838 848 2-s2.0-70349686948 10.1038/ki.2009.286
44. Li M., Peterson S., Husney D., Inaba M., Guo K., Kappas A., Ikehara S., Abraham N. G., Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 2007 6 5 567 571 2-s2.0-33947326097 (Pubitemid 46440429)
45. Datla S. R., Dusting G. J., Mori T. A., Taylor C. J., Croft K. D., Jiang F., Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase-derived oxidative stress. Hypertension 2007 50 4 636 642 2-s2.0-34548855958 10.1161/HYPERTENSIONAHA.107.092296 (Pubitemid 47442726)
46. Galkina E., Ley K., Leukocyte recruitment and vascular injury in diabetic nephropathy. Journal of the American Society of Nephrology 2006 17 2 368 377 2-s2.0-33645454310 10.1681/ASN.2005080859
47. Jin J. L., Sun H. L., Dong K. K., Jin R., Jung D. S., Kwak S. J., Seung H. K., Seung H. H., Jung E. L., Sung J. M., Ryu D. R., Yoo T. H., Dae S. H., Kang S. W., Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. American Journal of Physiology 2009 297 1 F200 F209 2-s2.0-67650661945 10.1152/ajprenal.90649.2008
48. Okada S., Shikata K., Matsuda M., Ogawa D., Usui H., Kido Y., Nagase R., Shikata Y., Makino H., Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 2003 52 10 2586 2593 2-s2.0-0141866840 10.2337/diabetes.52.10.2586 (Pubitemid 37210549)
49. Sugimoto H., Shikata K., Hirata K., Akiyama K., Matsuda M., Kushiro M., Shikata Y., Miyatake N., Miyasaka M., Makino H., Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 1997 46 12 2075 2081 2-s2.0-15144359119 (Pubitemid 27512099)
50. Wada T., Furuichi K., Sakai N., Iwata Y., Yoshimoto K., Shimizu M., Takeda S. I., Takasawa K., Yoshimura M., Kida H., Kobayashi K. I., Mukaida N., Naito T., Matsushima K., Yokoyama H., Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney International 2000 58 4 1492 1499 2-s2.0-0033806619 10.1046/j.1523-1755.2000. 00311.x
51. Ihm C. G., Park J. K., Hong S. P., Lee T. W., Cho B. S., Kim M. J., Cha D. R., Ha H., A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 1998 79 1 33 37 2-s2.0-0031900717 10.1159/000044988 (Pubitemid 28204035)
52. Kanamori H., Matsubara T., Mima A., Sumi E., Nagai K., Takahashi T., Abe H., Iehara N., Fukatsu A., Okamoto H., Kita T., Doi T., Arai H., Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochemical and Biophysical Research Communications 2007 360 4 772 777 2-s2.0-34447534187 10.1016/j.bbrc.2007.06.148 (Pubitemid 47077388)